Bench to Bedside Webinar Series

Print

Bench to Bedside (B2B) webinar series

Series cost: Free for members, $15 nonmembers
(registration includes all three webinars, plus on-demand access if unable to attend a live presentation)

In advance of the 2021 ARVO Bench to Bedside (B2B) Meeting, ARVO is hosting an educational webinar series that tackles the following need-to-know topics:

Raising Funds and Working as a Virtual Company

Sept. 16
11am – noon EDT

It is important for bench scientists who innovate to learn how and when to communicate with stakeholders who can potentially help fund discoveries into marketable products, drugs, and remedies that treat diseases that cause blindness. Following a period of strong financial results and investments in the ophthalmology space in 2019, most virtual startups have needed to pivot to prioritize other interests.

Featuring a panel of seasoned serial entrepreneurs, this webinar will help innovators and particularly those in virtual companies to ask questions and learn basic strategies and tactics to determine next steps in raising funds to sustain development. These will include the use of pitch decks and the identification of multiple funding platforms including nondiluted government grants, private equity, and co-licensing.

Learn more


Intellectual Property and Technology Transfer

Oct. 21
2 – 3pm EDT

Intellectual property is intrinsically related to the successful venture of new businesses. The protection of intellectual property through patents is often misunderstood, undervalued and overlooked by bench scientists and innovators. Many times, the scientist/innovator transfers the know-how surrounding a particular invention to a larger institution, but isn’t clear how this act benefits them in the long run.

Featuring a panel of scientists and experts in patent law and tech transfer, this webinar will permit scientists, and particularly those in the business of preventing blindness, to ask questions of experts and develop win-win strategies for technology transfer and patent protection.

Learn more

Regulatory Considerations

Nov. 18
2 – 3pm EDT

It is important for bench scientists who innovate to learn how and when to communicate with stakeholders who can potentially help translate laboratory discoveries into marketable products, drugs, and remedies that treat visual disorders.

This webinar will help innovators and new companies determine how to establish an early and productive dialogue with the FDA to gain valuable insights that could boost their chances of success and produce cost-effective clinical development strategies in drugs, devices, biologics and generics.

Learn more

About the B2B meeting

Learn about the ARVO Bench to Bedside meeting

B2B logo contest

Submit an eye-catching original design that represents the innovative nature of Bench to Bedside

Organizing Committee

Meet the experts who are putting together the Bench to Bedside (B2B) meeting

B2B in action

Learn how an academic startup became a $150 million public company